Zach Weinberg is the Co-Founder and CEO of Curie.Bio, a venture firm in New York dedicated to launching. See portfolio, sector focus and contact routes.
Zach Weinberg is the Co-Founder and CEO of Curie.Bio, a venture firm in New York dedicated to launching therapeutics companies, following his prior success as co-founder of Flatiron Health (acquired by Roche for $2 billion) and Invite Media (acquired by Google for $81 million)[2][5][10]. As an active angel investor, he targets pre-seed through Series B stages across AI, pharmaceuticals, biotech, consumer internet, enterprise, and SaaS, primarily in the United States[2]. His typical check size ranges from $100,000 to $5 million, and he is known for combining capital with operational support and access to drug hunters rather than just passive funding[2][13]. Notable portfolio companies include Plaid, Oscar Health, Clover Health, Color Genomics, Bark, Headway, and Spring Health, among over 97 total investments he has made[2][3][5]. Weinberg distinguishes himself with a “founder-first” philosophy and an operator’s mindset, aiming to redefine early-stage biotech investing by functioning like the “YC of Biotech”[11][13]. He has not published widely cited public writing, but his public interviews emphasize merging funding with hands-on operational guidance to increase startup success odds
This profile is part of the StartupFundraising investor database: focus, portfolio history, disclosed location and contact routes, refreshed as new filings and rounds are ingested. Founders use it to check fit before reaching out and to find investors in New York.
Investors like Zach Weinberg · Full investor directory · Investor access · Company funding database